Join us in Boston to hear about what the FDA’s ‘Innovative Initiatives’ enable

You are here: Home » Join us in Boston to hear about what the FDA’s ‘Innovative Initiatives’ enable

Nov 7, 2013 dm (0)

Ariana Pharma and Voisin Life Sciences Consulting present a conference in Boston on November 12th addressing the topic:

Product Development ‘What the FDA’s Innovative Initiatives enable’
Modern approaches for managing the complexity of product development

Ariana Pharma and Voisin Consulting Life Science are happy to host a seminar by Frederico Goodsaid, PhD – VP, Strategic Regulatory Intelligence at Vertex Pharmaceuticals and Antoinette Paone, MS – Sr Director, Head of Regulatory Affairs CMC at Vertex, who will discuss in detail the story of the development of Kalydeco.

This presentation will be hosted by Mohammad Afshar, CEO of Ariana, and Mark A. De Rosch, PhD – VP, regulatory Drugs/ Biologics at Voisin.

Please note that attendance to this conference is by invitation only. If you would like to join us, please contact Chad Mills.